4.5 Article

MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region

期刊

JOURNAL OF NEURO-ONCOLOGY
卷 155, 期 2, 页码 181-191

出版社

SPRINGER
DOI: 10.1007/s11060-021-03866-9

关键词

Radiomics; Magnetic resonance imaging (MRI); Glioblastoma multiforme (GBM); Low grade glioma; Peritumoral region

资金

  1. Hecht Foundation [1083]

向作者/读者索取更多资源

This study investigated the use of radiomics-based approach to distinguish between GBM PTR and LGG, showing that quantitative analysis of conventional MRI sequences can effectively differentiate between the two types of tumors.
Background The peritumoral region (PTR) of glioblastoma (GBM) appears as a T2W-hyperintensity and is composed of microscopic tumor and edema. Infiltrative low grade glioma (LGG) comprises tumor cells that seem similar to GBM PTR on MRI. The work here explored if a radiomics-based approach can distinguish between the two groups (tumor and edema versus tumor alone). Methods Patients with GBM and LGG imaged using a 1.5 T MRI were included in the study. Image data from cases of GBM PTR, and LGG were manually segmented guided by T2W hyperintensity. A set of 91 first-order and texture features were determined from each of T1W-contrast, and T2W-FLAIR, diffusion-weighted imaging sequences. Applying filtration techniques, a total of 3822 features were obtained. Different feature reduction techniques were employed, and a subsequent model was constructed using four machine learning classifiers. Leave-one-out cross-validation was used to assess classifier performance. Results The analysis included 42 GBM and 36 LGG. The best performance was obtained using AdaBoost classifier using all the features with a sensitivity, specificity, accuracy, and area of curve (AUC) of 91%, 86%, 89%, and 0.96, respectively. Amongst the feature selection techniques, the recursive feature elimination technique had the best results, with an AUC ranging from 0.87 to 0.92. Evaluation with the F-test resulted in the most consistent feature selection with 3 T1W-contrast texture features chosen in over 90% of instances. Conclusions Quantitative analysis of conventional MRI sequences can effectively demarcate GBM PTR from LGG, which is otherwise indistinguishable on visual estimation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions

K. Liang Zeng, Ahmed Abugarib, Hany Soliman, Sten Myrehaug, Zain A. Husain, Jay Detsky, Mark Ruschin, Aliaksandr Karotki, Eshetu G. Atenafu, Jeremie Larouche, Mikki Campbell, Pejman Maralani, Arjun Sahgal, Chia-Lin Tseng

Summary: Stereotactic body radiation therapy (SBRT) for spine metastases improves pain response rates compared with conventional external beam radiation therapy. This study investigates the optimal fractionation schedule and reports improved local control with dose-escalated 2-fraction spine SBRT. The results show that a dose of 28 Gy in 2 fractions is associated with better local control without increasing the risk of vertebral compression fracture (VCF).

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting

Hatef Mehrabian, Rachel W. Chan, Arjun Sahgal, Hanbo Chen, Aimee Theriault, Wilfred W. Lam, Sten Myrehaug, Chia-Lin Tseng, Zain Husain, Jay Detsky, Hany Soliman, Greg J. Stanisz

Summary: Saturation transfer MRI methods can be used to distinguish radiation necrosis from tumor progression. The magnetization transfer ratio provides the largest effect sizes among all metrics.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Letter Hematology

Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy

Bhausaheb Bagal, Rup Sarma, Sayak Dey, Lingaraj Nayak, Avinash Bonda, Jayant Goda, Nehal Khanna, Archya Dasgupta, Sangeeta Kakoti, Abhishek Chatarjee, Hasmukh Jain, Sridhar Epari, Siddhartha Laskar, Manju Sengar, Tejpal Gupta

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Oncology

Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)

Michael Yan, Minha Lee, Sten Myrehaug, Chia-Lin Tseng, Jay Detsky, Hanbo Chen, Sunit Das, Collins Yeboah, Nir Lipsman, Leodante Da Costa, Lori Holden, Chinthaka Heyn, Pejman Maralani, Mark Ruschin, Arjun Sahgal, Hany Soliman

Summary: This study aimed to report the outcomes of salvage hypofractionated stereotactic radiosurgery (HSRS) for brain metastases that failed prior HSRS/SRS. The results showed that HSRS can effectively control local failures and has low toxicity rates.

JOURNAL OF NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Pearls & Oy-sters: Primary Diffuse Leptomeningeal Melanocytosis A Diagnostic Conundrum

Jeevi Mona Priyadharshni Selvarajan, Sridhar Epari, Arpita Sahu, Archya Dasgupta, Abhishek Chatterjee, Tejpal Gupta

Summary: Primary diffuse leptomeningeal melanocytosis (PDLM) is a rare CNS tumor that presents diagnostic and therapeutic challenges due to its overlapping features with aseptic meningitis. This case report describes a patient initially treated for viral meningitis based on MRI and CSF analysis, but later diagnosed with PDLM through meningeal biopsy. The patient underwent ventriculoperitoneal shunt and craniospinal irradiation, and remains stable on regular surveillance. Optimal management of PDLM is controversial, with the role of radiotherapy, chemotherapy, targeted therapy, and immunotherapy still being debated.

NEUROLOGY (2023)

Article Health Care Sciences & Services

Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma

Debanjali Datta, Archya Dasgupta, Abhishek Chatterjee, Arpita Sahu, Kajari Bhattacharya, Lilawati Meena, Kishore Joshi, Ameya Puranik, Indraja Dev, Aliasgar Moiyadi, Prakash Shetty, Vikas Singh, Vijay Patil, Nandini Menon, Sridhar Epari, Ayushi Sahay, Tejpal Gupta

Summary: Re-irradiation (ReRT) is an effective treatment for recurrent/ progressive high-grade glioma (HGG). This study investigated the recurrence patterns following ReRT and found that local recurrence is most common within the high-dose region.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Review Neuroimaging

Post-ictal changes presenting as late pseudoprogression on MRI and PET in a patient with diffuse glioma: Case report and brief literature review

Swetha M. Nair, Arpita Sahu, Archya Dasgupta, Ameya Puranik, Tejpal Gupta

Summary: After completing adjuvant radiation and chemotherapy, imaging surveillance plays a crucial role in managing diffuse gliomas. The primary purpose of imaging is to identify recurrences earlier than clinical symptoms. Magnetic resonance imaging (MRI) is considered the preferred follow-up protocol due to its better soft tissue visualization and multiparametric nature. Differentiating between true recurrence and treatment-related changes is essential as their clinical courses differ. Additional functional imaging modalities can provide further information on the microenvironment. In equivocal cases, follow-up imaging at shorter intervals may be needed to resolve the diagnostic dilemma. This case report describes a patient with recurrent oligodendroglioma who presented with seizures five years after completing chemotherapy for recurrence. MRI revealed subtle new gyral thickening in the left frontal region, along with mild perfusion increase and patchy areas of raised choline. FET-PET showed an increased tumor-to-white matter ratio, supporting tumor recurrence. A short interval follow-up MRI performed two months later showed a decrease in gyral thickening and resolution of enhancing areas in the left frontal lobe. Repeat imaging one year later demonstrated stable disease status without new findings. Based on the resolution of changes without anti-tumor intervention, the authors conclude this to be peri-ictal pseudoprogression, the second reported case in India.

NEURORADIOLOGY JOURNAL (2023)

Review Oncology

Imaging Guidelines and Recommendations for Diagnosis, Surveillance, and Management of Pediatric CNS and Spinal Tumors

Tejas Kapadia, Arpita Sahu, Abhishek Mahajan, Ankita Ahuja, Abhishek Chatterjee, Amit Sahu, Anshu Warade, Shubham Padashetty, Antariksh Vijan, Natesan Chidambaranthan, Archya Dasgupta, Epari Sridhar, Ayushi Sahay, Prakash Shetty, Maya Prasad, Girish Chinnaswamy, Aliasgar Moiyadi, Tejpal Gupta, Foram Gala, Shilpa Sankhe

Summary: Central nervous system (CNS) tumors are the second most common cause of cancer in children, accounting for 20.1% of cancer burden. The most common pediatric brain tumors are astrocytoma and medulloblastoma, with slightly higher incidence of craniopharyngioma in Indian children compared to western high-income countries.

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2023)

Article Oncology

Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy

James Stewart, Arjun Sahgal, Mahtab M. Zadeh, Bahareh Moazen, Pejman Jabehdar Maralani, Stephen Breen, Angus Lau, Shawn Binda, Brian Keller, Zain Husain, Sten Myrehaug, Jay Detsky, Hany Soliman, Chia-Lin Tseng, Mark Ruschin

Summary: Magnetic resonance image-guided radiotherapy for intracranial indications is a promising advance, but uncertainties remain for both target localization after translation-only MR setup and intrafraction motion. This investigation quantified these uncertainties and developed a population-based PTV model to explore target and OAR volumetric coverage tradeoffs.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Clinical Neurology

Segmentation of Brain Metastases Using Background Layer Statistics (BLAST)

Chris Heyn, Alan R. Moody, Chia-Lin Tseng, Erin Wong, Tony Kang, Anish Kapadia, Peter Howard, Pejman Maralani, Sean Symons, Maged Goubran, Anne Martel, Hanbo Chen, Sten Myrehaug, Jay Detsky, Arjun Sahgal, Hany Soliman

Summary: This study demonstrates the accurate and reproducible segmentation of brain metastases using a semi-automated algorithm called BLAST. The results show that BLAST has potential as a tool for radiation planning and evaluating treatment response.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Oncology

Short-course Palliative Hypofractionated Radiotherapy in Patients with Poor-prognosis High-grade Glioma: Survival and Quality of Life Outcomes from a Prospective Phase II Study

Y. Baviskar, B. Likonda, S. Pant, S. Mokal, A. Pawar, A. Dasgupta, A. Chatterjee, T. Gupta

Summary: Longitudinal quality of life (QoL) outcomes and survival in patients with poor-prognosis high-grade glioma (HGG) treated with palliative hypofractionated radiotherapy were reported. Short-course palliative hypofractionated radiotherapy was associated with stable and/or improved QoL scores in several domains.

CLINICAL ONCOLOGY (2023)

Article Respiratory System

Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice

Chin Heng Fong, Nicholas Meti, Timothy Kruser, Jessica Weiss, Zhihui Amy Liu, Hirokazu Takami, Yoshitaka Narita, Fabio Ynoe de Moraes, Archya Dasgupta, Choo Khoon Ong, James C. H. Yang, Jih Hsiang Lee, Natalya Kosyak, Nicholas Pavlakis, Paul Kongkham, Mark Doherty, Natasha B. Leighl, David B. Shultz

Summary: International survey found significant variation in recommendations for the management of brain metastases in EGFRm or ALK+ NSCLC patients among medical, clinical, and radiation oncologists, as well as neurosurgeons. Development of multidisciplinary guidelines and further research on establishing optimal treatment strategies is warranted.

JOURNAL OF THORACIC DISEASE (2023)

Article Oncology

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer

Wee Loon Ong, Melanie Davidson, Patrick Cheung, Hans Chung, William Chu, Jay Detsky, Stanley Liu, Gerard Morton, Ewa Szumacher, Chia-Lin Tseng, Danny Vesprini, Ananth Ravi, Merrylee Mcguffin, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Meghan Kulasingham-Poon, Andrew Loblaw

Summary: This study aimed to correlate dosimetric parameters with toxicities and quality of life outcomes in two-fraction prostate stereotactic ablative radiotherapy (SABR). The results showed that dose parameters of the bladder and penile bulb were associated with toxicities, highlighting the importance of dose constraints in mitigating treatment-related side effects.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Multidisciplinary Sciences

Novel MRI-guided focussed ultrasound stimulated microbubble radiation enhancement treatment for breast cancer

Archya Dasgupta, Murtuza Saifuddin, Evan Mcnabb, Ling Ho, Lin Lu, Danny Vesprini, Irene Karam, Hany Soliman, Edward Chow, Sonal Gandhi, Maureen Trudeau, William Tran, Belinda Curpen, Greg Stanisz, Arjun Sahgal, Michael Kolios, Gregory J. Czarnota

Summary: Preclinical studies have shown that focused ultrasound stimulated microbubble rupture can activate the acid sphingomyelinase-ceramide pathway in endothelial cells. When delivered concurrently with radiotherapy, it leads to increased cell death and strong radiosensitization. This is the first human trial of using magnetic resonance imaging guided focused ultrasound microbubble treatment for breast malignancies.

SCIENTIFIC REPORTS (2023)

Review Oncology

Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma

Tejpal Gupta, Jeevi Mona Priyadharshni Selvarajan, Sadhana Kannan, Nandini Menon, Archya Dasgupta, Abhishek Chatterjee

Summary: This article reviews the efficacy of extended adjuvant temozolomide (TMZ) compared to standard adjuvant TMZ in newly diagnosed glioblastoma patients, based on nonrandomized studies and randomized controlled trials (RCTs). The results show that extended adjuvant TMZ is associated with a significant reduction in the risk of progression and death compared to standard adjuvant TMZ. However, the survival benefit of extended adjuvant TMZ is mainly driven by nonrandomized studies and is not observed when only data from RCTs are considered.

NEURO-ONCOLOGY ADVANCES (2023)

暂无数据